Mannkind MNKD Change in fair value of contingent consideration

Change in fair value of contingent consideration at other companies

Merit Medical SystemsMMSI

-$179K-117%

Other financials

Income statement

See full

Revenue$90.2M+15.1%

Gross profit$82.7M+10.8%

Operating income-$1.7M-107%

Net income-$16.6M-226%

EPS (diluted)-$0.05-225%

Balance sheet

See full

Cash & equivalents$52.8M+11.7%

Total debt$12.2M-9.4%

Total equity-$59.2M-1.0%

Total assets$744.4M+81.5%

Cash flow

See full

Operating cash flow-$5.4M+15.9%

CapEx$1.9M+470%

Free cash flow-$7.2M-8.0%

Valuation

See full

Market cap$1.19B+3.5%

Enterprise value$1.15B+3.0%

P/E228.5×—

P/S3.3×-0.6×

Profitability

See full

Gross margin91.5%-2.6pp

Operating margin23.3%+3.1pp

Net margin9.3%—

FCF margin13.8%—

Returns & leverage

See full

Return on equity-8.8%—

Debt / equity-0.2×—

Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Mannkind’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's change in fair value of contingent consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Mannkind's change in fair value of contingent consideration?: Mannkind (MNKD) reported change in fair value of contingent consideration of $257.25K in Q4 2025.
What does change in fair value of contingent consideration mean?: This represents the non-cash change in the fair value of liabilities related to earn-outs or milestone payments from previous business acquisitions. Fluctuations reflect updated management expectations regarding the probability of achieving specific clinical or commercial milestones.